Horizon Pharma submits supplemental New Drug Application for Ravicti oral liquid to expand age range to include newborns
Horizon Pharma plc (NASDAQ:HZNP) has submitted a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration (FDA)…